Global Coordination of Antimicrobial
The Joint Programming Initiative on Antimicrobial Resistance, JPIAMR, is a global collaborative organisation and platform, engaging 29 nations to curb antimicrobial resistance (AMR) with a One Health approach.
projects & networks
Social sciences as a cross-cutting theme in AMR research and innovation
The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR. This webinar gives an overview of how different social scientific fields could deepen the understanding of the AMR issue.
Tackling the emerging threat of fungal drug resistance
Invasive fungal infections pose a threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide. This live webinar will discuss the emerging threat of fungal drug resistance and identify opportunities and priorities in fungal resistance research.
Developing Diagnostic tools for Drug Resistant Infections for Human and Animal Health
In this workshop we will explore the main barriers to industry in developing diagnostic tools for drug-resistant infections for human and animal health and how JPIAMR and other stakeholders (industry, academia, funders, and regulatory agencies, among others) can work together to improve the translation of these developments.
Developing Novel Antimicrobial Therapeutics
JPIAMR, in partnership with Innovate UK KTN, are hosting this innovation workshop to provide information about the challenges in translating academic research to commercial and not-for-profit technology solutions.
Social sciences as a cross-cutting theme in JPIAMR research priorities
The development of resistance to antibiotics is a biological process, but the context that determines emergence and impact of resistance is underpinned by social aspects. Therefore, it is necessary to identify, understand and evaluate these social aspects to enable the prevention and control of AMR.
Consultation: antiparasitic and antiviral resistance
The JPIAMR has launched a round of consultation on antiparasitic and antiviral resistance. The information will be used for outlining research and innovation priorities in the Strategic Research and Innovation Agenda (SRIA) on Antimicrobial Resistance and informing the scope and direction of the candidate One Health AMR partnership.
Review from the JPIAMR SRIA fungal resistance group published in Nature Reviews Microbiology
The review “Tackling the emerging threat of antifungal resistance to human health” has been published in the April edition of Nature Reviews Microbiology. The review was written by the expert group on antifungals that led the broadening on the JPIAMR Strategic Research and Innovation Agenda in 2021.